{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:14:16Z","timestamp":1744200856210},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-022-04574-w","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:20:22Z","timestamp":1659090022000},"page":"3691-3700","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients"],"prefix":"10.1007","volume":"181","author":[{"given":"George","family":"Papadopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina","family":"Kosma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Papaevangelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Kanaka-Gantenbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Bountouvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Kitsiou-Tzeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"4574_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/ajmg.a.61485","volume":"182","author":"AM Gross","year":"2020","unstructured":"Gross AM, Frone M, Gripp KW, Gelb BD, Schoyer L, Schill L, Stronach B, Biesecker LG, Esposito D, Hernandez ER, Legius E, Loh ML, Martin S, Morrison DK, Rauen KA, Wolters PL, Zand D, McCormick F, Savage SA, Stewart DR, Widemann BC, Yohe ME (2020) Advancing RAS\/RASopathy therapies: an NCI-sponsored intramural and extramural collaboration for the study of RASopathies. Am J Med Genet A 182:866\u2013876","journal-title":"Am J Med Genet A"},{"key":"4574_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","volume":"381","author":"AE Roberts","year":"2013","unstructured":"Roberts AE, Allanson JE, Tartaglia M, Gelb BD (2013) Noonan syndrome. Lancet 381:333\u2013342","journal-title":"Lancet"},{"key":"4574_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/MPH.0b013e31805d8f57","volume":"29","author":"M Moschovi","year":"2007","unstructured":"Moschovi M, Touliatou V, Papadopoulou A, Mayakou MA, Nikolaidou-Karpathiou P, Kitsiou-Tzeli S (2007) Rhabdomyosarcoma in a patient with Noonan syndrome phenotype and review of the literature. J Pediatr Hematol Oncol 29:341\u2013344","journal-title":"J Pediatr Hematol Oncol"},{"key":"4574_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02699050500284218","volume":"24","author":"S Yoon","year":"2006","unstructured":"Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21\u201344","journal-title":"Growth Factors"},{"key":"4574_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen KA (2013) The RASopathies. Annu Rev Genomics Hum Genet 14:355\u2013369","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"4574_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465\u2013468","journal-title":"Nat Genet"},{"key":"4574_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/ejhg.2014.115","volume":"23","author":"LE Vissers","year":"2015","unstructured":"Vissers LE, Bonetti M, Paardekooper Overman J, Nillesen WM, Frints SG, de Ligt J, Zampino G, Justino A, Machado JC, Schepens M, Brunner HG, Veltman JA, Scheffer H, Gros P, Costa JL, Tartaglia M, van der Burgt I, Yntema HG, den Hertog J (2015) Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome. Eur J Hum Genet 23:317\u2013324","journal-title":"Eur J Hum Genet"},{"key":"4574_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41431-020-00743-3","volume":"29","author":"J Brinkmann","year":"2021","unstructured":"Brinkmann J, Lissewski C, Pinna V, Vial Y, Pantaleoni F, Lepri F, Daniele P, Burnyte B, Cuturilo G, Fauth C, Gezdirici A, Kotzot D, Gulec EY, Iotova V, Schanze D, Ramond F, Havlovicova M, Utine GE, Simsek-Kiper PO, Stoyanova M, Verloes A, De Luca A, Tartaglia M, Cave H, Zenker M (2021) The clinical significance of A2ML1 variants in Noonan syndrome has to be reconsidered. Eur J Hum Genet 29:524\u2013527","journal-title":"Eur J Hum Genet"},{"key":"4574_CR9","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/humu.23624","volume":"39","author":"AR Grant","year":"2018","unstructured":"Grant AR, Cushman BJ, Cave H, Dillon MW, Gelb BD, Gripp KW, Lee JA, Mason-Suares H, Rauen KA, Tartaglia M, Vincent LM, Zenker M (2018) Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework. Hum Mutat 39:1485\u20131493","journal-title":"Hum Mutat"},{"key":"4574_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jmedgenet-2015-103018","volume":"52","author":"GL Yamamoto","year":"2015","unstructured":"Yamamoto GL, Aguena M, Gos M, Hung C, Pilch J, Fahiminiya S, Abramowicz A, Cristian I, Buscarilli M, Naslavsky MS, Malaquias AC, Zatz M, Bodamer O, Majewski J, Jorge AA, Pereira AC, Kim CA, Passos-Bueno MR, Bertola DR (2015) Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. J Med Genet 52:413\u2013421","journal-title":"J Med Genet"},{"key":"4574_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.advms.2017.07.001","volume":"63","author":"A Tafazoli","year":"2018","unstructured":"Tafazoli A, Eshraghi P, Pantaleoni F, Vakili R, Moghaddassian M, Ghahraman M, Muto V, Paolacci S, Golyan FF, Abbaszadegan MR (2018) Novel mutations and their genotype-phenotype correlations in patients with Noonan syndrome, using next-generation sequencing. Adv Med Sci 63:87\u201393","journal-title":"Adv Med Sci"},{"key":"4574_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12881-020-0986-5","volume":"21","author":"JP Athota","year":"2020","unstructured":"Athota JP, Bhat M, Nampoothiri S, Gowrishankar K, Narayanachar SG, Puttamallesh V, Farooque MO, Shetty S (2020) Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations. BMC Med Genet 21:50","journal-title":"BMC Med Genet"},{"key":"4574_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ajhg.2013.05.021","volume":"93","author":"Y Aoki","year":"2013","unstructured":"Aoki Y, Niihori T, Banjo T, Okamoto N, Mizuno S, Kurosawa K, Ogata T, Takada F, Yano M, Ando T, Hoshika T, Barnett C, Ohashi H, Kawame H, Hasegawa T, Okutani T, Nagashima T, Hasegawa S, Funayama R, Nakayama K, Inoue S, Watanabe Y, Ogura T, Matsubara Y (2013) Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS\/MAPK pathway syndrome. Am J Hum Genet 93:173\u2013180","journal-title":"Am J Hum Genet"},{"key":"4574_CR14","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ajmg.a.40456","volume":"179","author":"R Nelson","year":"2019","unstructured":"Nelson R (2019) Mek inhibitor reverses hypertrophic cardiomyopathy in RIT1 mutated Noonan syndrome: for the first time, hypertrophic cardiomyopathy was reversed in Noonan syndrome associated with a RIT1 mutation. Am J Med Genet A 179:1408\u20131409","journal-title":"Am J Med Genet A"},{"key":"4574_CR15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/ng1641","volume":"37","author":"Y Aoki","year":"2005","unstructured":"Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, Filocamo M, Kato K, Suzuki Y, Kure S, Matsubara Y (2005) Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37:1038\u20131040","journal-title":"Nat Genet"},{"key":"4574_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1126\/science.1124642","volume":"311","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA (2006) Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311:1287\u20131290","journal-title":"Science"},{"key":"4574_CR17","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/ng2113","volume":"39","author":"H Brems","year":"2007","unstructured":"Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E (2007) Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 39:1120\u20131126","journal-title":"Nat Genet"},{"key":"4574_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00431-011-1487-5","volume":"171","author":"A Papadopoulou","year":"2012","unstructured":"Papadopoulou A, Issakidis M, Gole E, Kosma K, Fryssira H, Fretzayas A, Nicolaidou P, Kitsiou-Tzeli S (2012) Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment. Eur J Pediatr 171:51\u201358","journal-title":"Eur J Pediatr"},{"key":"4574_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1172-2-4","volume":"2","author":"I van der Burgt","year":"2007","unstructured":"van der Burgt I (2007) Noonan syndrome. Orphanet J Rare Dis 2:4","journal-title":"Orphanet J Rare Dis"},{"key":"4574_CR20","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1073\/pnas.1324128111","volume":"111","author":"PC Chen","year":"2014","unstructured":"Chen PC, Yin J, Yu HW, Yuan T, Fernandez M, Yung CK, Trinh QM, Peltekova VD, Reid JG, Tworog-Dube E, Morgan MB, Muzny DM, Stein L, McPherson JD, Roberts AE, Gibbs RA, Neel BG, Kucherlapati R (2014) Next-generation sequencing identifies rare variants associated with Noonan syndrome. Proc Natl Acad Sci U S A 111:11473\u201311478","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4574_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt I, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD (2006) Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 78:279\u2013290","journal-title":"Am J Hum Genet"},{"key":"4574_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fgene.2019.00333","volume":"10","author":"C Tekendo-Ngongang","year":"2019","unstructured":"Tekendo-Ngongang C, Agenbag G, Bope CD, Esterhuizen AI, Wonkam A (2019) Noonan syndrome in South Africa: clinical and molecular profiles. Front Genet 10:333","journal-title":"Front Genet"},{"key":"4574_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpam.2016.06.003","volume":"3","author":"I El Bouchikhi","year":"2016","unstructured":"El Bouchikhi I, Belhassan K, Moufid FZ, Iraqui Houssaini M, Bouguenouch L, Samri I, Atmani S, Ouldim K (2016) Noonan syndrome-causing genes: molecular update and an assessment of the mutation rate. Int J Pediatr Adolesc Med 3:133\u2013142","journal-title":"Int J Pediatr Adolesc Med"},{"key":"4574_CR24","first-page":"330","volume":"117","author":"J Chinton","year":"2019","unstructured":"Chinton J, Huckstadt V, Moresco A, Gravina LP, Obregon MG (2019) Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina. Arch Argent Pediatr 117:330\u2013337","journal-title":"Arch Argent Pediatr"},{"key":"4574_CR25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ajmg.c.31851","volume":"184","author":"DR Bertola","year":"2020","unstructured":"Bertola DR, Castro MAA, Yamamoto GL, Honjo RS, Ceroni JR, Buscarilli MM, Freitas AB, Malaquias AC, Pereira AC, Jorge AAL, Passos-Bueno MR, Kim CA (2020) Phenotype-genotype analysis of 242 individuals with RASopathies: 18-year experience of a tertiary center in Brazil. Am J Med Genet C Semin Med Genet 184:896\u2013911","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4574_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00439-015-1627-5","volume":"135","author":"M Yaoita","year":"2016","unstructured":"Yaoita M, Niihori T, Mizuno S, Okamoto N, Hayashi S, Watanabe A, Yokozawa M et al (2016) Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations. Hum Genet 135:209\u2013222","journal-title":"Hum Genet"},{"key":"4574_CR27","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1002\/ajmg.a.36722","volume":"164A","author":"DR Bertola","year":"2014","unstructured":"Bertola DR, Yamamoto GL, Almeida TF, Buscarilli M, Jorge AA, Malaquias AC, Kim CA, Takahashi VN, Passos-Bueno MR, Pereira AC (2014) Further evidence of the importance of RIT1 in Noonan syndrome. Am J Med Genet A 164A:2952\u20132957","journal-title":"Am J Med Genet A"},{"key":"4574_CR28","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/ajmg.a.36646","volume":"164A","author":"M Gos","year":"2014","unstructured":"Gos M, Fahiminiya S, Poznanski J, Klapecki J, Obersztyn E, Piotrowicz M, Wierzba J, Posmyk R, Bal J, Majewski J (2014) Contribution of RIT1 mutations to the pathogenesis of Noonan syndrome: four new cases and further evidence of heterogeneity. Am J Med Genet A 164A:2310\u20132316","journal-title":"Am J Med Genet A"},{"key":"4574_CR29","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/gim.2016.32","volume":"18","author":"K Kouz","year":"2016","unstructured":"Kouz K, Lissewski C, Spranger S, Mitter D, Riess A, Lopez-Gonzalez V, Luttgen S et al (2016) Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation. Genet Med 18:1226\u20131234","journal-title":"Genet Med"},{"key":"4574_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ng1939","volume":"39","author":"M Tartaglia","year":"2007","unstructured":"Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, Pandit B, Oishi K, Martinelli S, Schackwitz W, Ustaszewska A, Martin J, Bristow J, Carta C, Lepri F, Neri C, Vasta I, Gibson K, Curry CJ, Siguero JP, Digilio MC, Zampino G, Dallapiccola B, Bar-Sagi D, Gelb BD (2007) Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39:75\u201379","journal-title":"Nat Genet"},{"key":"4574_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng1926","volume":"39","author":"AE Roberts","year":"2007","unstructured":"Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, Li L, Yassin Y, Tamburino AM, Neel BG, Kucherlapati RS (2007) Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 39:70\u201374","journal-title":"Nat Genet"},{"key":"4574_CR32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/humu.21492","volume":"32","author":"F Lepri","year":"2011","unstructured":"Lepri F, De Luca A, Stella L, Rossi C, Baldassarre G, Pantaleoni F, Cordeddu V et al (2011) SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations. Hum Mutat 32:760\u2013772","journal-title":"Hum Mutat"},{"key":"4574_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng1748","volume":"38","author":"S Schubbert","year":"2006","unstructured":"Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, Niemeyer CM, Shannon K, Kratz CP (2006) Germline KRAS mutations cause Noonan syndrome. Nat Genet 38:331\u2013336","journal-title":"Nat Genet"},{"key":"4574_CR34","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.1073\/pnas.1419895112","volume":"112","author":"MT Mazhab-Jafari","year":"2015","unstructured":"Mazhab-Jafari MT, Marshall CB, Smith MJ, Gasmi-Seabrook GM, Stathopulos PB, Inagaki F, Kay LE, Neel BG, Ikura M (2015) Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site. Proc Natl Acad Sci U S A 112:6625\u20136630","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4574_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ng1749","volume":"38","author":"T Niihori","year":"2006","unstructured":"Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, Okamoto N, Hennekam RC, Gillessen-Kaesbach G, Wieczorek D, Kavamura MI, Kurosawa K, Ohashi H, Wilson L, Heron D, Bonneau D, Corona G, Kaname T, Naritomi K, Baumann C, Matsumoto N, Kato K, Kure S, Matsubara Y (2006) Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 38:294\u2013296","journal-title":"Nat Genet"},{"key":"4574_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/504394","volume":"79","author":"C Carta","year":"2006","unstructured":"Carta C, Pantaleoni F, Bocchinfuso G, Stella L, Vasta I, Sarkozy A, Digilio C, Palleschi A, Pizzuti A, Grammatico P, Zampino G, Dallapiccola B, Gelb BD, Tartaglia M (2006) Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet 79:129\u2013135","journal-title":"Am J Hum Genet"},{"key":"4574_CR37","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ng2078","volume":"39","author":"MA Razzaque","year":"2007","unstructured":"Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, Kamisago M, Momma K, Katayama H, Nakagawa M, Fujiwara Y, Matsushima M, Mizuno K, Tokuyama M, Hirota H, Muneuchi J, Higashinakagawa T, Matsuoka R (2007) Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 39:1013\u20131017","journal-title":"Nat Genet"},{"key":"4574_CR38","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.425","volume":"41","author":"V Cordeddu","year":"2009","unstructured":"Cordeddu V, Di Schiavi E, Pennacchio LA, Ma\u2019ayan A, Sarkozy A, Fodale V, Cecchetti S et al (2009) Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet 41:1022\u20131026","journal-title":"Nat Genet"},{"key":"4574_CR39","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1002\/ajmg.a.36697","volume":"164A","author":"G Baldassarre","year":"2014","unstructured":"Baldassarre G, Mussa A, Banaudi E, Rossi C, Tartaglia M, Silengo M, Ferrero GB (2014) Phenotypic variability associated with the invariant SHOC2 c.4A>G (p.Ser2Gly) missense mutation. Am J Med Genet A 164A:3120\u20133125","journal-title":"Am J Med Genet A"},{"key":"4574_CR40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ajhg.2010.06.015","volume":"87","author":"S Martinelli","year":"2010","unstructured":"Martinelli S, De Luca A, Stellacci E, Rossi C, Checquolo S, Lepri F, Caputo V et al (2010) Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype. Am J Hum Genet 87:250\u2013257","journal-title":"Am J Hum Genet"},{"key":"4574_CR41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/ng.641","volume":"42","author":"CM Niemeyer","year":"2010","unstructured":"Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S et al (2010) Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet 42:794\u2013800","journal-title":"Nat Genet"},{"key":"4574_CR42","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1038\/s41598-018-20894-0","volume":"8","author":"GKC Leung","year":"2018","unstructured":"Leung GKC, Luk HM, Tang VHM, Gao WW, Mak CCY, Yu MHC, Wong WL, Chu YWY, Yang WL, Wong WHS, Ma ACH, Leung AYH, Jin DY, Chan KYK, Allanson J, Lo IFM, Chung BHY (2018) Integrating functional analysis in the next-generation sequencing diagnostic pipeline of RASopathies. Sci Rep 8:2421","journal-title":"Sci Rep"},{"key":"4574_CR43","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1172\/JCI46399","volume":"121","author":"BD Gelb","year":"2011","unstructured":"Gelb BD, Tartaglia M (2011) RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it. J Clin Invest 121:844\u2013847","journal-title":"J Clin Invest"},{"key":"4574_CR44","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1172\/JCI43910","volume":"120","author":"PC Chen","year":"2010","unstructured":"Chen PC, Wakimoto H, Conner D, Araki T, Yuan T, Roberts A, Seidman C, Bronson R, Neel B, Seidman JG, Kucherlapati R (2010) Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome-associated Sos1 mutation. J Clin Invest 120:4353\u20134365","journal-title":"J Clin Invest"},{"key":"4574_CR45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1172\/JCI44929","volume":"121","author":"X Wu","year":"2011","unstructured":"Wu X, Simpson J, Hong JH, Kim KH, Thavarajah NK, Backx PH, Neel BG, Araki T (2011) MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf 1(L613V) mutation. J Clin Invest 121:1009\u20131025","journal-title":"J Clin Invest"},{"key":"4574_CR46","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.hfc.2017.12.005","volume":"14","author":"G Calcagni","year":"2018","unstructured":"Calcagni G, Adorisio R, Martinelli S, Grutter G, Baban A, Versacci P, Digilio MC, Drago F, Gelb BD, Tartaglia M, Marino B (2018) Clinical presentation and natural history of hypertrophic cardiomyopathy in RASopathies. Heart Fail Clin 14:225\u2013235","journal-title":"Heart Fail Clin"},{"key":"4574_CR47","doi-asserted-by":"crossref","unstructured":"Dori Y, Smith C, Pinto E, Snyder K, March ME, Hakonarson H, Belasco J (2020) Severe lymphatic disorder resolved with MEK inhibition in a patient with Noonan syndrome and SOS1 mutation. Pediatrics 146","DOI":"10.1542\/peds.2020-0167"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04574-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-022-04574-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04574-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T15:13:39Z","timestamp":1666451619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-022-04574-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["4574"],"URL":"https:\/\/doi.org\/10.1007\/s00431-022-04574-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and its later amendments. Medical ethical approval was granted by the local medical ethics committee of Attikon University general hospital with the file number (4492\/16.07.2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the participants or\/and the parents of the participating children, as well as patients\u2019 assess where applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}